• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agency of Health Technology Assessment of Uruguay
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Healthcare Quality Institute
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [25027 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2024     Austrian Institute for Health Technology Assessment (AIHTA) [Use of telepathology for intraoperative frozen section examination]
2010     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Use of telemedicine between Rigshospitalet and Bornholm Hospital: report of a pilot project]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Use of surrogate end points in HTA]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Use of structured support programmes in the monitoring of heart failure patients - an evidence map]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Use of statutory health insurance (BARMER) data in IQWiG's dossier assessment procedure]
2024     Basque Office for Health Technology Assessment (OSTEBA) [Use of self-sampling for the detection of human papillomavirus in cervical cancer screening]
2014     Basque Office for Health Technology Assessment (OSTEBA) [Use of radiography in diagnosing low back pain: systematic review]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of radioactive seeds for the preoperative localization of non-palpable breast tumours]
2011     Andalusian Health Technology Assessment Area (AETSA) [Use of QALYs in different clinical situations]
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of prolotherapy in the treatment of chronic musculoskeletal conditions]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of prescription opioids for pain in Quebecers aged 65 years and older]
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of medullary neurostimulators for the treatment of chronic non-cancer pain]
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of long-term left ventricular assist devices for advanced heart failure in Quebec from 2010 to 2012]
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of intravenous immunoglobulins - a review of management strategy experiences and the available evidence]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of intrathecal pumps in chronic pain management: efficacy, safety, clinical indications and organizational methods]
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of intrathecal pumps for the treatment of chronic non-cancer pain]
2022     Agencia de Evaluacion de Tecnologias Sanitarias (AETS-ISCIII) [Use of indocyanine green in colorectal and hepato-biliopancreatic surgery]
2019     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Use of incentive spirometry for the prevention of pulmonary complications following surgery]
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of Fertil ProMD products in the treatment of infertility]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of extracorporeal membrane oxygenation (ECMO) in adults in Quebec: patient characteristics, care trajectories and clinical outcomes, 2017 to 2023]
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Use of class 3b and class 4 lasers and intense pulsed light sources for cosmetic procedures in non-medical settings]
2023     Institute for Clinical Effectiveness and Health Policy (IECS) [Use of biomaterials in tympanoplasty for tympanic membrane repair]
2023     The Danish Health Technology Council (DHTC) [Use of artificial intelligence as clinical decision-support in colonoscopy for the diagnosis of neoplastic disease]
2013     Institute for Clinical Effectiveness and Health Policy (IECS) [Use of antibiotic-loaded bone cement in primary hip and knee arthroplasty]
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Use and performance of clinical mammography in Denmark]
2010     The Swedish Council on Health Technology Assessment (SBU) [Urine specimens in diagnosing chlamydia in women]
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Urine proteomic analysis for detection of diabetic nephropathy in patients with diabetes mellitus and arterial hypertension]
2011     Committee for New Health Technology Assessment (CNHTA) [Urine neural thread protein]
2011     Committee for New Health Technology Assessment (CNHTA) [Urine neural thread protein test]
2014     Canary Health Service [Urine markers for the prediction of kidney transplant rejection]
2009     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Urine and blood glucose self-measurement in diabetes mellitus type 2]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Urinary proteome analysis for detection of diabetic nephropathy in patients with diabetes mellitus and arterial hypertension. Update of Commission D13-01. - Rapid Report]
2013     The Swedish Council on Health Technology Assessment (SBU) [Urinary incontinence in the elderly]
2009     The Regional Health Technology Assessment Centre (HTA-centrum) [Urgent or late carotid endarterectomy in patients with symptomatic stenosis of the internal carotid artery]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Upper respiratory tract surgical techniques for the treatment of patients with obstructive sleep apnea syndrome]
2017     Basque Office for Health Technology Assessment (OSTEBA) [Updating of the shared work system for systematic reviews of the evidence and critical appraisal (FLC 3.0 Platform)]
2014     Andalusian Health Technology Assessment Area (AETSA) [Updating of selection criteria for direct antiviral agents for patients with chronic hepatitis c in a severe clinical situation in the SSPA]
2023     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Update: Functioning and disability - An evidence map]
2009     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Update search on Report A05-19A (cholinesterase inhibitors in the treatment of Alzheimer's Disease) - Rapid report]
2023     Austrian Institute for Health Technology Assessment (AIHTA) [Update PET/PET-CT evidence for need based planning in the area of oncology]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Update of the guideline synopsis for the DMP "rheumatoid arthritis" - rapid report]
2007     Andalusian Health Technology Assessment Area (AETSA) [Update of the guide for the introduction of new drugs (GINF)]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Upadacitinib (ulcerative colitis) - Benefit assessment according to §35a Social Code Book V]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Upadacitinib (rheumatoid arthritis) - Benefit assessment according to §35a Social Code Book V]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Upadacitinib (psoriatic arthritis) - Benefit assessment according to §35a Social Code Book V]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Upadacitinib (psoriatic arthritis) - Addendum to Commission A21-15]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Upadacitinib (giant cell arteritis) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Upadacitinib (giant cell arteritis) – Addendum to Project A25-66]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Upadacitinib (Crohn disease) - Benefit assessment according to §35a Social Code Book V]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Upadacitinib (axial spondyloarthritis) - Benefit assessment according to §35a Social Code Book V]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Upadacitinib (atopic dermatitis) - Benefit assessment according to §35a Social Code Book V]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Upadacitinib (ankylosing spondylitis) - Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Unresectable or metastatic melanoma; assessment according to §35a Social Code Book V; search for disease registries]
2008     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Unrelated donor stem cell transplantation acquired severe aplastic anaemia]
2010     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Unrelated donor allogeneic stem cell transplantation for Hodgkin's lymphoma]
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Unplanned hospital readmissions in Catalonia]
2007     Andalusian Health Technology Assessment Area (AETSA) [Universal leukorreduction. A systematic review of the literature and an economic assessment]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Uncertainty in the efficiency frontiers]
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Umeclidinium/vilanterol - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Umeclidinium - Benefit assessment according to §35a Social Code Book V]
2002     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Umbilical artery Doppler ultrasonography in high risk pregnancies]
2025     HTA South [Ultraviolet light disinfection of flexible endoscopes without working channels: a systematic review and assessment of medical, economical, and organisational aspects]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for uterine fibroids: Assessment according to §137h Social Code Book V]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for uterine fibroids - Addendum to commission H16-02B]
2019     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for uterine fibroids - 2nd addendum to commission H16-02B]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for secondary malignant neoplasms of the liver and the intrahepatic bile ducts - Assessment according to §137h Social Code Book V]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for secondary malignant neoplasms of the liver and the intrahepatic bile ducts - Addendum to commission H16-02E]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for secondary malignant neoplasms of the bone - Assessment according to §137h Social Code Book V]
2019     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for malignant neoplasms of the pancreas not treatable by surgery - 3rd addendum to commission H16-02C]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for malignant neoplasms of the pancreas - second Addendum to Commission H16-02C]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for malignant neoplasms of the pancreas - Assessment according to §137h Social Code Book V]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for malignant neoplasms of the pancreas - Addendum to commission H16-02C]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for malignant neoplasms of the liver and the intrahepatic bile ducts - Assessment according to §137h Social Code Book V]
2019     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for malignant neoplasms of the liver and the intrahepatic bile ducts - 2nd addendum to commission H16-02D]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for malignant neoplasms of the liver and intrahepatic bile ducts - Addendum to commission H16-02D]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for malignant neoplasms of the bone and the joint cartilage: Assessment according to §137h Social Code Book V]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for endometriosis of the uterus: Assessment according to §137h Social Code Book V]
2022     Institute for Clinical Effectiveness and Health Policy (IECS) [Ultrasound therapy for scar tissue]
2008     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound screening in pregnancy - test quality with regard to the detection rates of foetal abnormalities]
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound screening for abdominal aortic aneurysms]
2004     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Ultrasound imaging in the diagnosis of carpal tunnel syndrome]
2014     Haute Autorite de sante (HAS) [Ultrasound guidance for peripheral nerve blockade]
2013     Institute for Clinical Effectiveness and Health Policy (IECS) [Ultrasensitive C-reactive protein as a prognostic biomarker for cardiovascular disease]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Ulipristal in uterine myomatosis]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ublituximab (multiple sclerosis) – Benefit assessment according to §35a Social Code Book V]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ublituximab (multiple sclerosis) – Addendum to Project A24-13]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ublituximab (multiple sclerosis) – 2nd Addendum to Project A24-13]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [UAE and MRgFUS versus myoma enucleation - Evidence report for the S3 guideline on diagnosis and treatment of benign diseases of the uterus]
2003     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Type 2 diabetes. Health technology assessment of screening, diagnosis and treatment - systematic review]
2008     The Swedish Council on Health Technology Assessment (SBU) [Tympanostomy tube insertion for otitis media in children]
2019     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Turoctocog alfa pegol - Benefit assessment according to §35a Social Code Book V]
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Turoctocog alfa - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2019     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tumour-treating fields in addition to current standard therapy for glioblastoma as first-line treatment - Rapid report]
2025     Regione Emilia Romagna (RER) [Tumour treating fields (TTFields) for the treatment of patients with newly diagnosed and recurrent glioblastoma]
2002     Basque Office for Health Technology Assessment (OSTEBA) [Tumour markers in certain cancer locations]
2025     Norwegian Medical Products Agency (NOMA) [Tumor-treating fields (Optune) for treatment of glioblastoma: a rapid health technology assessment with submitted documentation]
2013     Andalusian Health Technology Assessment Area (AETSA) [Tumor treating fields therapy (TTF) for glioblastoma. A systematic review of the literature]
2025     Canary Health Service [Tumor treating fields (TTFields) therapy in people with newly diagnosed glioblastoma]
2020     Andalusian Health Technology Assessment Area (AETSA) [Tumor field therapy in the treatment of glioblastoma. Update]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Tumor biomarkers related to the management of people with breast cancer]